Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

In this multicenter, single‐arm, phase II study, the efficacy and safety of ibrutinib were examined in Japanese patients with relapsed or refractory mantle cell lymphoma (MCL). Patients (age ≥20 years) with relapsed or refractory MCL who had progressed after receiving at least one prior treatment re...

Full description

Bibliographic Details
Main Authors: Maruyama, Dai, Nagai, Hirokazu, Fukuhara, Noriko, Kitano, Toshiyuki, Ishikawa, Takayuki, Shibayama, Hirohiko, Choi, Ilseung, Hatake, Kiyohiko, Uchida, Toshiki, Nishikori, Momoko, Kinoshita, Tomohiro, Matsuno, Yoshihiro, Nishikawa, Tomoaki, Takahara, Satoko, Tobinai, Kensei
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198949/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198949/

Similar Items